gip/glp-1 GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GIP and GLP-1: similarities and

Clinicians should be aware that the FDA contraindications for products with the thyroid C-cell tumor boxed warning include personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2 (MEN 2)

However, these drugs are known to cause a plethora of adverse effects such as weight gain, edema, intestinal discomfort and hypoglycemia (2)

New formulations and delivery methods are changing the frequency conversation

GLP-1 can induce the expression of FNDC5 in pancreatic -cells through the interaction of its downstream transcription factor cAMP-response element binding protein (CREB) with binding elements in the FNDC5 promoter, thereby promoting the conversion of WAT to BAT and enhancing energy metabolism [85]

"I understand the importance of lifestyle modification, and I am committed to continuing those efforts